Cargando…

The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population

PURPOSE: Emerging evidence suggested that metabolic dysfunction-associated fatty liver disease (MAFLD) was significantly associated with atherosclerotic diseases. Atherosclerosis in the peripheral arteries is the most common cause of peripheral arterial disease (PAD), which has not been substantiall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xiao-Hui, Liu, Bo, Lei, Fang, Liu, Ye-Mao, Zhang, Xingyuan, Chen, Ze, Zhang, Peng, Zhang, Xiao-Jing, She, Zhi-Gang, Cai, Jingjing, Wang, Jin-Hua, Li, Hongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926992/ https://www.ncbi.nlm.nih.gov/pubmed/36798909 http://dx.doi.org/10.2147/DMSO.S394414

Ejemplares similares

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
por: Hu, Yingying, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

The association of apolipoprotein B with chronic kidney disease in the Chinese population
por: Xu, Yu, et al.
Publicado: (2023)

Heavy Disease Burden of High Systolic Blood Pressure During 1990-2019: Highlighting Regional, Sex, and Age Specific Strategies in Blood Pressure Control
por: Chen, Ming-Ming, et al.
Publicado: (2021)

Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes
por: Lin, Lijin, et al.
Publicado: (2021)

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
por: Yu, Yao, et al.
Publicado: (2018)

Association between questionnaire-based and accelerometer-based physical activity and the incidence of chronic kidney disease using data from UK Biobank: a prospective cohort study
por: Zhang, Xingyuan, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
por: Zhou, Xiao-Dong, et al.
Publicado: (2022)

Prevalence and trend of atrial fibrillation and its associated risk factors among the population from nationwide health check-up centers in China, 2012–2017
por: Sun, Tao, et al.
Publicado: (2023)

Association between autonomic dysfunction and olfactory dysfunction in Parkinson’s disease in southern Chinese
por: Wang, Xin-Yi, et al.
Publicado: (2019)

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
por: Tian, Ruifeng, et al.
Publicado: (2023)

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
por: Gu, Zhan, et al.
Publicado: (2020)

Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study
por: Zhang, Ru, et al.
Publicado: (2022)

Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China
por: Liao, Shenling, et al.
Publicado: (2022)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
por: Xiao, Yuji, et al.
Publicado: (2023)

Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population
por: Cai, Jinwei, et al.
Publicado: (2021)

Long-Term Exposure to Fine Particulate Constituents and Vascular Damage in a Population with Metabolic Abnormality in China
por: Lin, Lijin, et al.
Publicado: (2023)

Fatty acid binding protein 3 is associated with peripheral arterial disease
por: Syed, Muzammil H., et al.
Publicado: (2020)

Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study
por: Hu, Qian, et al.
Publicado: (2022)

Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
por: Chen, Xu, et al.
Publicado: (2021)

Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population
por: Lee, Guan Huei, et al.
Publicado: (2020)

Association between 1p13 polymorphisms and peripheral arterial disease in a Chinese population with diabetes
por: Qin, Jiangyuan, et al.
Publicado: (2018)

Association between nontraditional lipid profiles and peripheral arterial disease in Chinese adults with hypertension
por: Ding, Congcong, et al.
Publicado: (2020)

Projection of global burden and risk factors for aortic aneurysm – timely warning for greater emphasis on managing blood pressure
por: Huang, Xuewei, et al.
Publicado: (2022)

Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms
por: He, Yuan, et al.
Publicado: (2022)

Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population
por: Xu, Yingyu, et al.
Publicado: (2019)

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
por: Liu, Jiayi, et al.
Publicado: (2022)

Abnormal expression of Tim‐3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients
por: Liu, Hongliang, et al.
Publicado: (2016)

Association between serum uric acid levels and peripheral artery disease in Chinese adults with hypertension
por: Han, Fengyu, et al.
Publicado: (2023)

Identification of polyunsaturated fatty acids related key modules and genes in metabolic dysfunction-associated fatty liver disease using WGCNA analysis
por: Xiao, Cheng, et al.
Publicado: (2022)

Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease
por: Liu, Wen-Yue, et al.
Publicado: (2021)

Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data
por: Zou, Jiahua, et al.
Publicado: (2022)

Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Lu, Chuan, et al.
Publicado: (2023)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
por: Li, Hejun, et al.
Publicado: (2022)

Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease
por: Xiao, Pei, et al.
Publicado: (2022)

Perception of the association between erectile dysfunction and cardiovascular disease among Chinese physicians: an online survey
por: Li, Dong-Jie, et al.
Publicado: (2020)

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
por: Lin, Huapeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6cbfek8294ppv07ic2btoti7un